arrow
E

Edgar Carnero Contentti

hospital aleman buenos aires
H指数:23
被引数:2,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD): A global review of publicly listed patient disease registries and databases

髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)和视神经脊髓炎谱系障碍(NMOSD)的全球映射:对公开列出的患者疾病登记册和数据库的综述

2026-11-110
PRE
Latin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice

拉丁美洲关于磁共振成像在临床实践中神经脊髓炎光谱障碍中作用的共识建议

2026-10-260
PRE
Dorsolateral nigral hyperintensity in idiopathic REM sleep behavior disorder: a systematic review and meta-analysis

特发性快速眼动睡眠行为障碍中背外侧黑质高信号:一项系统评价和Meta分析

2026-08-270
OAAI
Collaborative Latin American Imaging Network In Neuroimmunology Research (BRAIMS): Rationale, Structure, Challenges, and Future Directions

拉丁美洲神经免疫学影像学协作网络(BRAIMS):理论基础、结构、挑战及未来方向

2026-04-130
PRE
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder

真实世界中eculizumab在AQP4-IgG阳性视神经脊髓炎谱系障碍中的有效性和安全性

2026-01-080
OAAI
The postdoc paradox: a career without a path

博士后悖论:没有发展路径的职业生涯

BRAIN
IF11.7
2025-11-010
PRE
Seasonal and monthly patterns of relapses in adult MOG-IgG-associated disease (MOGAD): A retrospective analysis from Latin America

成人MOG-IgG相关疾病(MOGAD)复发的时间季节性和月度模式:一项来自拉丁美洲的回顾性分析

2025-10-270
PRE
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study

克拉屈滨作为50岁以上多发性硬化患者治疗方案的疗效与安全性:一项真实世界研究

2025-10-140
PRE
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study

NMOSD、MOGAD和双重血清阴性的脱髓鞘综合征的复发和残疾预测因子:一项国际多中心回顾性队列研究

2025-10-070
PRE
Comparative analysis of AQP4-IgG-positive and AQP4-IgG-negative NMOSD: A multicenter study in Latin America

AQP4-IgG阳性与AQP4-IgG阴性NMOSD的比较分析:一项拉丁美洲多中心研究

2025-10-060
PRE
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments

在高疗效治疗时代,与复发活动无关的进展(PIRA)

2025-09-210
PRE
Academia in the throes of faceless bureaucracy

学术界正受着无面官僚主义的折磨

Brain
IF11.7
2025-06-090
PRE
Neuromyelitis optica spectrum disorder in Latin America: a global data share initiative

视神经脊髓炎谱系障碍在拉丁美洲:一项全球数据共享倡议

2025-06-010
PRE